NOW BUZZING 헤어컬러가 브라운과 오렌지로 쪼개지는 이… · 코치, 85주년에 '낡음'을 미래로 바꾸… · 프레피룩, 왜 더 플라자에서 다시 태어났…◆
NOW BUZZING 헤어컬러가 브라운과 오렌지로 쪼개지는 이… · 코치, 85주년에 '낡음'을 미래로 바꾸… · 프레피룩, 왜 더 플라자에서 다시 태어났…◆
JELIBI
⌕ SUBSCRIBE
SEOUL · DAILY · ISSUE No.327 WE TRIED IT · THE PICK · BEHIND IT 2026.09.30 · WED
JELIBI
⌕ SUB
Beauty Body Gadget Bites Buzz World
HOME/GADGET/BEHIND IT
GADGET BEHIND IT · 5 MIN READ

엔비디아·릴리, AI 신약 개발 공동혁신 랩 출범

JD 젤리비 편집국 · 2026.02.27 SHARE · COPY LINK

무슨 발표인가

  • 5년간 최대 $10억 투자 규모
  • 캘리포니아 베이에어리어 소재
  • 생물학·의학 전문가와 AI 엔지니어 협업

5년, 최대 10억 달러, 캘리포니아

원문 (영어)

News Summary: NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab infrastructure will be built on the NVIDIA BioNeMo platform and the NVIDIA Vera Rubin architecture.

NVIDIA and Lilly will pioneer robotics and physical AI to accelerate and scale medicine discovery and production. J.P. Morgan Healthcare Conference —NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

The lab brings together Lilly’s world-leading expertise in discovering, developing and manufacturing medicines with NVIDIA’s leadership in AI, accelerated computing and AI infrastructure. The two companies will invest up to $1 billion in talent, infrastructure and compute over five years to support the new AI co-innovation lab.

Based in the San Francisco Bay Area, the lab will co-locate Lilly domain experts in biology, science and medicine with top AI model builders and engineers from NVIDIA, allowing them to work side by side to generate large-scale data and build powerful AI models that can accelerate medicine development, using NVIDIA BioNeMo as the critical platform.

“AI is transforming every industry, and its most profound impact will be in life sciences,” said Jensen Huang, founder and CEO of NVIDIA. “NVIDIA and Lilly are bringing together the best of our industries to invent a new blueprint for drug discovery — one where scientists can explore vast biological and chemical spaces in silico before a single molecule is made.”

“For nearly 150 years, we’ve been working to bring life-changing medicines to patients,” said David A.

원문: NVIDIA News — "NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI" (2026-02-27) 공식 원문: https://nvidianews.nvidia.com/news/nvidia-and-lilly-announce-co-innovation-lab-to-reinvent-drug-discovery-in-the-age-of-ai

#NVIDIA News
THE JELIBI BRIEF

A small team that reads too much internet so you don't have to.

SUBSCRIBE →
GADGET

인스로픽, 안전장치 없이 사이버공격 자동화 모델 공개

GADGET

삼성 6개 계열사, AI 인프라 기업 헬릭스에 10억 달러 투자

GADGET

TBC, AWS와 협력해 신경세포 유래 AI 비디오 모델 출시

← GADGET BEHIND IT

엔비디아·릴리, AI 신약 개발 공동혁신 랩 출범

젤리비 편집국·2026.02.27·5 MIN
IN THIS PIECE
무슨 발표인가 원문 (영어)

무슨 발표인가

  • 5년간 최대 $10억 투자 규모
  • 캘리포니아 베이에어리어 소재
  • 생물학·의학 전문가와 AI 엔지니어 협업

5년, 최대 10억 달러, 캘리포니아

원문 (영어)

News Summary: NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab infrastructure will be built on the NVIDIA BioNeMo platform and the NVIDIA Vera Rubin architecture.

NVIDIA and Lilly will pioneer robotics and physical AI to accelerate and scale medicine discovery and production. J.P. Morgan Healthcare Conference —NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

The lab brings together Lilly’s world-leading expertise in discovering, developing and manufacturing medicines with NVIDIA’s leadership in AI, accelerated computing and AI infrastructure. The two companies will invest up to $1 billion in talent, infrastructure and compute over five years to support the new AI co-innovation lab.

Based in the San Francisco Bay Area, the lab will co-locate Lilly domain experts in biology, science and medicine with top AI model builders and engineers from NVIDIA, allowing them to work side by side to generate large-scale data and build powerful AI models that can accelerate medicine development, using NVIDIA BioNeMo as the critical platform.

“AI is transforming every industry, and its most profound impact will be in life sciences,” said Jensen Huang, founder and CEO of NVIDIA. “NVIDIA and Lilly are bringing together the best of our industries to invent a new blueprint for drug discovery — one where scientists can explore vast biological and chemical spaces in silico before a single molecule is made.”

“For nearly 150 years, we’ve been working to bring life-changing medicines to patients,” said David A.

원문: NVIDIA News — "NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI" (2026-02-27) 공식 원문: https://nvidianews.nvidia.com/news/nvidia-and-lilly-announce-co-innovation-lab-to-reinvent-drug-discovery-in-the-age-of-ai

#NVIDIA News
THE JELIBI BRIEF

A small team that reads too much internet so you don't have to.

SUBSCRIBE →
MORE IN BEHIND IT
질병관리청, WHO 의료대응수단 네트워크 포럼 참석해 감염병 대응 협력 강화인스로픽, 안전장치 없이 사이버공격 자동화 모델 공개삼성 6개 계열사, AI 인프라 기업 헬릭스에 10억 달러 투자Samsung, 세계 심장의 날 캠페인으로 심장 건강 관리 강조CJ도너스캠프, 아동복지시설 교사 260명 교사교육 실시
THE JELIBI BRIEF

인터넷을 너무 많이 보는 팀이 대신 골라 옵니다.

SUBSCRIBE

바로가기 등록하시면, 더 쉽게 찾아보실 수 있습니다.